Kenneth H. Yu, MD

Kenneth H. Yu, MD

Medical Oncologist

Clinical Expertise

Pancreatic, Hepatobiliary, and Other Gastrointestinal Malignancies

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Yu accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me


MSc, University of Pennsylvania; MD, Johns Hopkins University


Internal Medicine - Hospital of the University of Pennsylvania


Hematology/Oncology - Hospital of the University of Pennsylvania

Board Certifications

Medical Oncology

I am a medical oncologist with expertise in the treatment of pancreatic, hepatobiliary, and other gastrointestinal cancers. My research is focused on two areas: first, the discovery and implementation of biomarkers for the diagnosis of pancreatic cancer, and second, the development of more-effective treatments for pancreatic cancer. My research program is funded by the National Cancer Institute/National Institutes of Health, the Lustgarten Foundation, and the Thompson Family Foundation.


Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res. 2005; 4(5):1742-51.

Hewitt MR, Yu KH. Treatment update for metastatic pancreatic cancer. Community Oncology. 2006; 3(7) :428-30 .

Yu KH, Barry CG, Austin D, Busch CM, Sangar V, Rustgi AK, Blair IA. Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery. J Proteome Res. 2009; 8(3) :1565-76.